Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP4-614O4.11 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | KRT76 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | PPP1R13L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | UCHL3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | UBTF | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | OGT | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | AGO2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | ITPRIPL1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | PPP2R2D | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | ODF3L2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |